News of the dayAstraZeneca sheds thousands of jobs
03.02.12 London - AstraZeneca tries to shed some weight, anticipating a tough year ahead. 7,300 jobs will be gone soon, the Anglo-Swedish drug company said in a statement. Research and development operations will be cancelled in...moreNo allergy against the stock market
02.02.12 Bagneux - DBV Technologies is planning an IPO on Euronext Paris. The French pharmaceutical group specialising in the treatment of allergies was founded in 2002. DBV's proprietary technology Viaskin is used to administer an... moreAn ocean of fuels
01.02.12 Copenhagen/Bangalore – Biofuels need reliable sources of biomass. Novozymes now looks to the ocean to secure biomass. The Danish enzyme specialist announced an exploratory research agreement with Sea6 Energy from India. The... moreProduct of the WeekKaluza 1.2 Cytometry Software
03.02.12 NYON, Switzerland Kaluza 1.2 from Beckman Coulter, Inc., an enhanced version of the company’s highly acclaimed flow cytometry software, adds new multiple visualization tools and processes data at blazing speeds, allowing...more